🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareCost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — looking for input Page 3

Cost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — looking for input

SkepticalSean Sat, Sep 27, 2025 at 2:23 AM 14 replies 1,388 viewsPage 3 of 3
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Sep 27, 2025 at 6:38 AM#11
Dr.BariatricHTX said:
Cost-effectiveness analysis GLP-1 is not that straightforward in my experience

This is exactly right. Dr.BariatricHTX articulated what I have been trying to explain to my doctor for months. The Cost-effectiveness aspect is the most important factor.

Last edited: Sep 27, 2025 at 11:38 AM
33 9LondonLisa, mike_nyc, VendorMark and 30 others
Reply Quote Save Share Report
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
Sep 27, 2025 at 6:55 AM#12

Reading this thread on Cost-effectiveness hits close to home. Night shift nurse — I started at 299 lbs and felt like I would tried everything.

15 months on tirz and I am a different person. Not just the 74 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Cost-effectiveness — take the leap. It was the best health decision I have ever made. ❤️

29 1carl_compliance, DanielChem_CHI, marco_milano and 26 others
Reply Quote Save Share Report
FranDenver
Member
267
1,123
Oct 2024
Denver, CO
Sep 27, 2025 at 7:12 AM#13

Dr.EM_Chicago — that is really helpful context on Cost-effectiveness. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

Last edited: Sep 27, 2025 at 1:12 PM
28 22BariatricNurseD, MASHdoc_SA, GenomicsKate and 25 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Sep 27, 2025 at 7:29 AM#14

To answer tane_welly's question specifically:

From a clinical standpoint, Cost-effectiveness analysis is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

40 14tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 37 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Sep 27, 2025 at 7:46 AM#15

Bookmarked 📌 The Cost-effectiveness info in this thread is essential. Coming back to this for sure.

Last edited: Sep 27, 2025 at 9:46 AM
16 2Dr.ObesityLA, NurseKim_ATL, paul_denver and 13 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register